Page 5 - நம்பகத்தன்மை வாழ்க்கை அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Outlook on the Biologic Therapeutic Drugs Global Market to 2025 - Growing Geriatric Population is Driving the Industry

Share this article Share this article ResearchAndMarkets.com s offering. The current report offers a detailed picture of the biologics market. This report highlights the current and future market potential for biologics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as key market players. This report details market shares for biologics based on product and geography. Based on product, the market is segmented into therapeutic proteins, vaccines and other segments. Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base y

United statesEli lillyLaura woodGlycotope gmbhEli lilly and coGlaxosmithkline plcBaxter internationalReliance life sciencesConsumption trends in healthTeva pharmaceutical industries ltdPorter five forces analysisInvolvement of large pharmaceutical companiesRoche ltdCustom researchDendreon pharmaceuticals llcImpact on health technology assessment

Global TNF Alpha Inhibitors Markets 2020-2030: Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), & Simponi (golimumab)

Global TNF Alpha Inhibitors Markets 2020-2030: Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), & Simponi (golimumab)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesAryogen biopharmaHanall biopharmaZydus cadilaSamsung bioepisLaura woodCelgene corporationReliance life sciencesPfizer incAbbvie incNovartis internationalJohnson services incOffice hours callDrug administrationMomenta pharmaceuticalsSegmentation by route of administration

Global $7 18 Billion Biosimilar Monoclonal Antibodies Markets, 2015-2019, 2023F, 2025F, 2030F

Share this article Share this article ResearchAndMarkets.com s offering. The global biosimilar monoclonal antibodies market is expected to decline from $3.21 billion in 2019 to $3.04 billion in 2020 at a compound annual growth rate (CAGR) of -5.18%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $7.18 billion in 2023 at a CAGR of 33.13%. This report focuses on biosimilar monoclonal antibodies market which is experiencing strong growth. The report gives a guide to the biosimilar monoclonal antibodies market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

United statesCoherus biosciencesHisun pharmaCelgen biopharmaLaura woodReliance life sciencesBoehringer ingelheimTorrent pharmaceuticalsOffice hours callGenor biopharma coDrug administrationE st office hours callIntas pharmaceuticalsReddys laboratories ltdAurobindo pharmaEuropean medicines agency

Ankylosing Spondylitis Market Research Report by Drug, by Type of Molecule, by Mechanism Of Action, by Route Of Administration, by Dosage Forms, by End User - Global Forecast to 2025

Ankylosing Spondylitis Market Research Report by Drug, by Type of Molecule, by Mechanism Of Action, by Route Of Administration, by Dosage Forms, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 Ankylosing Spondylitis Market Research Report by Drug (Cimzia, Cosentyx, Enbrel, Humira, and Remicade), by Type of Molecule (Biologics and Small Molecules), by Mechanism Of Action, by Route Of Administration, by Dosage Forms, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 February 24, 2021 08:34 ET | Source: ReportLinker ReportLinker Lyon, FRANCE New York, Feb. 24, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Ankylosing Spondylitis Market Research Report by Drug, by Type of Molecule, by Mechanism Of Action, by Route Of Administration, by Dosage Forms, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 - https://www.reportlinker

New yorkUnited statesUnited kingdomSouth africaUnited arab emiratesSaudi arabiaSouth koreaCh boehringer sohnIzana bioscienceEli lillyBristol myers squibbCelgene corporationSandoz international gmbReliance life sciencesBiothera pharmaceuticals incShanghai pharmaceuticals holding co ltd

Stem Cells Market By Component, Technology, Deployment, End-User, Regions, Segments & Forecast, 2021

Stem Cells Market By Component, Technology, Deployment, End-User, Regions, Segments & Forecast, 2021
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaApceth gmbAsia pacificReliance life sciences pvtMesoblast ltdUs stem cell incWise guy research consultants pvtResearch newswireWise guy research consultantsGlobal stem cells market researchOsiris therapeutics incSurgical incBiotime incPluristem therapeutics incCell cure neurosciences ltd